ClinTec

Glasgow, United Kingdom Founded: 1997 • Age: 29 yrs
Clinical research services are provided globally to pharmaceutical industries.
Annual revenue - Latest available
Total funding $12.5M 1 rounds
Employees 39 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About ClinTec

ClinTec is a company based in Glasgow (United Kingdom) founded in 1997 by Rabinder Buttar. ClinTec has raised $12.51 million across 1 funding round from investors including Elephant Capital. The company has 39 employees as of March 30, 2024. ClinTec operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.

  • Headquarter Glasgow, United Kingdom
  • Employees 39 as on 30 Mar, 2024
  • Founders Rabinder Buttar
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Clintec (India) International Private Limited
  • Date of Incorporation 06 May, 2002
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$4.37 K (USD)
    -101.6
    as on Mar 31, 2022
  • EBITDA
    Not available
  • Total Equity Funding
    $12.51 M (USD)

    in 1 rounds

  • Latest Funding Round
    $12.51 M (USD), Private Equity Round

    Aug 19, 2010

  • Investors
  • Employee Count
    39

    as on Mar 30, 2024

  • Acquired by

    (Dec 01, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of ClinTec

Headcount 10000+
Employee Profiles 1261
Board Members and Advisors 9
Employee Profiles
People
Lynda Curtin
Director Clinical Operations -site Management
People
Oana Borse
Director, Strategic Sourcing R&ds
People
Jessika Talbot
Clinical Research Associate II (fsp- Astrazeneca)
People
David Peig
Senior Director - Rare Disease BU & GTM Strategy

Unlock access to complete

Board Members and Advisors
people
Colleen Goggins
Director
people
James A. Fasano
Director
people
John G. Danhakl
Director
people
Todd B. Sisitsky
Director

Unlock access to complete

Funding Insights of ClinTec

ClinTec has successfully raised a total of $12.51M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $12.51 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in ClinTec

ClinTec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Elephant Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments in growth companies in India, leveraging networks for returns.
Locked Locked Locked
Premium access

Investor details for ClinTec

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ClinTec

Investments
Premium access

Investment portfolio details for ClinTec

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ClinTec

Premium access

Detailed financials for ClinTec

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Clintec Comparisons

ClinTec Primary company
Description
Clinical research services are provided globally to pharmace...
Location
Glasgow, United Kingdom
Founded Year
1997
Annual Revenue
Not available
Net Profit
-$4.37 K (USD)
EBITDA
Not available
Employees
39
As of 2024
Premium access

Peer comparison for ClinTec

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ClinTec

ClinTec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapies for cancer and inflammatory diseases are developed.
Locked Locked Locked
CRO clinical development services are provided by Syneos Health.
Locked Locked Locked
Full-service CRO expertise in influenza and oncology research is offered.
Locked Locked Locked
Outsourced contract research organization services are provided to clients.
Locked Locked Locked
Full-service clinical research organization services are provided globally by Parexel.
Locked Locked Locked
Global full-service CRO services are delivered in over 80 countries.
Premium access

Detailed competitors of ClinTec

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Clintec

Data specialist Lawson joins Talking Medicines
Dailybusinessgroup5 years ago
Premium access

Complete news archive for ClinTec

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ClinTec

ClinTec was founded in 1997 and raised its 1st funding round 13 years after it was founded.

ClinTec is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.

Rabinder Buttar is the current CEO of ClinTec. They have also founded this company.

ClinTec is a funded company, having raised a total of $12.51M across 1 funding round to date.

As of Mar 30, 2024, the latest employee count at ClinTec is 39.

ClinTec was founded in 1997 in Glasgow, United Kingdom, as a clinical research organization. Services are offered to pharmaceutical, biotechnology, and medical device sectors, including project management, monitoring, data management, biostatistics, quality assurance, and medical writing. Consulting on regulatory matters, feasibility studies, and training is also provided, along with patient recruitment and resourcing. Operations span therapeutic areas such as oncology, neurology, and cardiology, with a global reach.

ClinTec's top competitors include Emmes, Syneos Health and ClinChoice.

ClinTec has 1 investor. Key investors include Elephant Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available